QAi Prostate Dx & QAi Prostate Grade
Introducing QAi Prostate Dx and QAi Prostate Grade by Qritive, advanced solutions tailored for precise prostate cancer screening and grading. Prostate adenocarcinoma, the most prevalent prostate cancer type globally, continues to escalate in incidence. QAi Prostate stands as a robust tool specifically designed for accurate adenocarcinoma detection.
These solutions optimize lab workflows, enhancing efficiency by enabling screening, triage, and prioritization of cases, offering vital support to pathologists. With a clinical-grade approach, QAi Prostate Grade utilizes AI-based tumor classification to discern between benign and malignant cases, providing precise boundaries through segmentation maps for simplified comprehension and swift assessment at slide or Region of Interest (ROI) levels.
The AI-generated summary report includes comprehensive insights derived from analyzed parameters, such as stromal, glandular, benign, and malignant tissue areas. Presented through data tables and charts at the case level, this report offers a detailed understanding of prostate anatomy, indicating tumor classification at corresponding gross label locations. QAi Prostate by Qritive delivers detailed, explainable AI-driven insights, empowering pathologists with valuable information for more accurate and efficient assessments.
